Australian government funds $1M for development of Covax-19® vaccine (MTPConnect)

The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®. Sharen Pringle, Vaxine’s Business […]

The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide

17 Developers Are Testing Coronavirus Vaccines on Humans. Here’s What You Need to Know About Them   Country: Australia Trial stage: Phase I The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to […]

Flinders University scientists led by Tasmanian Professor Nik Petrovsky on track to have a vaccine by the end of the year

The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials. But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia? Duration: 17min 40sec Broadcast: Fri 3 Jul 2020, 8:30am link to the podcast

Vaxine Pty Ltd announces COVID-19 vaccine collaboration with Kazakh National Agrarian University

Vaxine executes COVID-19 vaccine memorandum of understanding with theInternational Centre for Vaccinology at the Kazakh National Agrarian University. “Pandemic viruses do not respect national borders and consequently, it is vitally important that scientists from all countries openly work together in a collaborative fashion to counter such global threats”, said Professor Nikolai Petrovsky MBBS, FRACP, Ph.D., […]

Vaxine and University of Georgia Complete First Stage of COVID-19 Ferret Challenge Studies

COVAX-19® immunizations completed at University of Georgia to assess COVID-19 protection. Vaxine Pty Ltd announced today completion of the immunization phase of ferret challenge studies being conducted at the University of Georgia to test the ability of Vaxine’s promising COVAX-19® vaccine to protect against COVID-19. “We have already seen that COVAX-19® vaccine induces potent antibody […]

Pharma research firm APC partners to develop Covid-19 vaccine with Vaxine

Irish company working with Australian vaccine developer Vaxine on a new candidate Irish pharmaceutical research company APC has partnered with an Australian biotech firm to accelerate the development and launch of a vaccine for coronavirus. The pharmaceutical research company, which designs, develops, and markets proprietary engineering platform technologies that reduce the time, cost, and risk […]

Flinders targets COVID-19 vaccine

South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic. The team is headed by Nikolai Petrovsky, Flinders University Professor and Research Director at Vaxine.

Vaccine World Asia 2019

Vaccine World Asia 2019, 25-27 November, Singapore. Advancing vaccine business, technology & innovation in developing countries to facilitate access to new vaccines and combat global pandemic threats. Vaccines World Asia 2019 Brings You: High Level Decision Makers from the Immunotherapy and Vaccine Industry Key Stakeholder Companies in Immunotherapy and Vaccines Hours of Networking Round-table Discussions […]